Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Vassal

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1975
Immunoblastic lymphosarcoma, a cytological and clinical entity?G Mathé, D Belpomme, D Dantchev, et al.
Anticancer Research|January 1, 1982
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trialJ L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon]J L Misset, G Mathé, J Gastiaburu, et al.
British Medical Journal|March 24, 1973
Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phaseL Schwarzenberg, G Mathé, P Pouillart, et al.
La Nouvelle Presse Medicale|May 3, 1975
[Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases]G Mathé, J L Amiel, L Schwarzenberg, et al.
Cancer Treatment Reports|May 1, 1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristineG Mathé, J L Misset, F De Vassal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route]J L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1977
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumoursG Mathé, B Serrou, M Hayat, et al.
La Nouvelle Presse Medicale|February 18, 1978
[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]G Marthé, J L Misset, F de Vassal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisationJ L Misset, G Mathé, M Tubiana, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1975
Immunoblastic lymphosarcoma, a cytological and clinical entity?G Mathé, D Belpomme, D Dantchev, et al.
Anticancer Research|January 1, 1982
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trialJ L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon]J L Misset, G Mathé, J Gastiaburu, et al.
British Medical Journal|March 24, 1973
Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phaseL Schwarzenberg, G Mathé, P Pouillart, et al.
La Nouvelle Presse Medicale|May 3, 1975
[Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases]G Mathé, J L Amiel, L Schwarzenberg, et al.
Cancer Treatment Reports|May 1, 1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristineG Mathé, J L Misset, F De Vassal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route]J L Misset, G Mathé, J Gastiaburu, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1977
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumoursG Mathé, B Serrou, M Hayat, et al.
La Nouvelle Presse Medicale|February 18, 1978
[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]G Marthé, J L Misset, F de Vassal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisationJ L Misset, G Mathé, M Tubiana, et al.
Pageof 4